Why Profound Medical Corp.’s (PROF) Stock Is Up 5.78%
As of Monday, November 02, Profound Medical Corp.’s PROF share price has surged by 5.78%, which has investors questioning if this is right time to sell.Michael Rose
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Michael Rose
Rosalio Madrigal
Michael Rose
Tudor Pop
| Share Statistics | PROF | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $236.4 | $363.7 | 31% |
|
| Shares Out (Mil) | 36.6 | 41.1 | 40% |
|
| Institutional Ownership | 94.7% | 82.7% | 65% |
|
| Float (Mil) | 35.6 | 36.7 | 39% |
|
| Beta | 0.56 | 0.89 | 31% |
|
| Avg Daily Volume (000s) | 135 | 326 | 39% |
|
| Price Change (52-week) |
5.6% | 54.6% | 60% |
|
| Growth | PROF | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 17.1% | 11.8% | 77% |
|
| Net Income (5yr) | (14.5%) | (5.8%) | 26% |
|
| EPS (5yr) | (2.4%) | 10.6% | 28 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (47.5%) | (15.6%) | 8% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 4 | 4 | 5 | |
| Current EPS | ($0.258) | ($0.928) | ($0.612) | |
| Month Ago EPS | ($0.187) | ($0.824) | ($0.578) | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 1 | 0 | 0 | |
| Three Months Ago EPS | ($0.180) | ($0.838) | ($0.571) | |
| Year/Year Chg | 22.3% | (34.1%) | (94.3%) | |
| Financials | PROF | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $24 | $123 | 14% |
|
| Net Income (TTM) (Mil) | ($33) | ($9) | 19% |
|
| EPS (TTM) | ($0.930) | ($0.300) | 21% |
|
| Operating Cash Flow (TTM) (Mil) | ($32) | ($1) | 12% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $3 | $21 | 21% |
|
| Enterprise Value (Q1) (Mil) | $241 | $381 | 28% |
|
| Valuation | PROF | Industry Median |
Percentile (All Stocks) |
|
| P/B | 5.53 | 2.41 | 85% |
|
| P/E | na | 25.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.3 | na |
|
| Ratios | PROF | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 73.9% | 59.5% | 84% |
|
| Net Margin | (137.5%) | (5.0%) | 6% |
|
| ROA | (64.7%) | (10.4%) | 9% |
|
| ROE | (87.0%) | (8.4%) | 10% |
|
| Liabilities to Assets | 26.9% | 45.8% | 19% |
|
| F-Score | 5 | 4 | 50% |
|
Profound Medical Corp. did not pass any screens on 11/20/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors